- Home
- OPK vs ALVO Comparison
OPK vs ALVO Comparison
Compare OPK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | ALVO |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPK | ALVO |
|---|---|---|
| Price | $1.50 | $4.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $1.60 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 4.3M | 1.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | $4.24 | $18.63 |
| P/E Ratio | ★ N/A | $18.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $2.94 |
| 52 Week High | $1.73 | $9.25 |
Technical Indicators
Market Signals| Indicator | OPK | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 62.48 | 72.45 |
| Support Level | $1.26 | $4.67 |
| Resistance Level | $1.55 | $5.46 |
| Average True Range (ATR) | 0.05 | 0.27 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 87.50 | 72.46 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.